The Xerosis Market Size was valued at USD 8.61 Billion in 2023. The Global Xerosis industry is projected to grow from USD 9.15 Billion in 2024 to USD 14.92 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.20% during the forecast period (2024 - 2032).
Xerosis also known as xeroderma is a condition characterised by excessive dry skin caused by over cleansing, excessive showers, living in areas of low humidity, dehydration, extended exposure to sun, ageing etc. Xerosis commonly affects the scalp, lower legs, arms and thighs with symptoms such as scaling which is the visible peeling of the outer skin layer, itching, and skin cracking. Other symptoms are dry, itchy, and scaly skin, flaky skin, irritated red skin etc. Xerosis is common in the winter due to cold dry air causing the skin to lose moisture. Xerosis can also be caused by a deficiency of vitamin A, vitamin D, due to systemic illness and side effects associated with medication. The standard treatment of Xerosis is application of emollients, moisturizers etc.
Xerosis also responds well to lifestyle changes. Hormonal changes due to ageing, diabetes etc. affect the sweat glands and sebaceous glands which increases the chances of Xerosis. The application of highly occlusive barriers to skin such as petrolatum, vegetable oils, mineral oil etc. provides excellent results. Lanolin, a natural lipid derived from sheep's wool, provides replacement of the natural lipids in human skin and is one of the most effective treatments for xeroderma. The main drawback of lanolin is that it is a common allergen and that it is a thick waxy substance that is difficult and inconvenient for use.
A pair of products that work in tandem to combat severe skin dryness is being launched by Curèl, a Japanese line of facial moisturizers and cleansers that are specifically intended for dry and sensitive skin. This announcement was made in February 2024. The new set, which will be available in Japan starting on April 4, 2024, includes the Curél Outfit-for-Skin Potion, a moisturizer that diffuses onto the skin as an ultra-thin veil, and the Veil Creator, a specialized diffuser that is used to apply the ultra-thin veil and create an artificial second skin. Upon wrapping the skin, the veil emits moisturizing ingredients that penetrate the stratum corneum to maintain skin hydration and alleviate concerns regarding severe skin dryness.
Kao's "Fine Fiber Technology" is the foundation of the ultra-thin membrane technology utilized in the new potion and diffuser. This technique enables the direct diffusion of ultra-fine fibers onto the epidermis in the form of a laminated, ultra-thin veil.
In 2019, Kao Corporation introduced skincare applications that were based on the Fine Fiber Technology. However, Curél is currently utilizing the technology to introduce a new skincare method that is specifically designed for intensive hydration care. In reality, the initial iterations of the technology necessitated a two-step care regimen, which began with the application of a specialized nourishing essence and culminated in the diffusion of the veil. In order to streamline the application process, Kao scientists created a hydrating beauty essence as the primary constituent that constitutes the veil.
The Curél Outfit-for-Skin Potion is the first product to incorporate the newest solution, "bleed-out technology," which involves the incorporation of moisturizing ingredients into the spaces between the ultra-fine fibers of the veil to nourish the skin. The moisturizing ingredients penetrate the stratum corneum, ensuring that the ultra-thin veil remains securely in position like a second skin.
Xerosis market is driven by factors such as growing awareness, influence of lifestyle and fashion industry, increasing cases of skin dryness due to increasing pollution etc. Xerosis market constraints are huge number of low quality players which have fragmented the market, self-correcting nature of Xerosis etc. There is also a huge ambiguity regarding the claims of many products which is a threat to the future market. Pressure to reduce cost due to cut throat competition has forced many players especially those operating from poor regions to substitute high cost materials with lower ones often compromising on quality which has reduced the credibility of the Xerosis market for quality manufacturers. Thus the returns on advertisement are believed to fall in the future.
Procter & Gamble, Alba Botanica, Avalon Organics, Johnson & Johnson Consumer Inc., Galderma Laboratories, Clarins, Unilever, Hempz, L’Oréal, Avon, Croda International Plc, Beiersdorf, Estee Lauder, United-Guardian, Inc., Dow Corning Corp. and others.
Global xerosis market is segmented on the basis of treatment, causes and end users.
Based on treatment, the market has been segmented as emollients, moisturizer, humidifier, oils and others.
Based on the causes, the market has been segmented as eczema, psoriasis, diabetes, hypothyroidism, aging, and others.
Based on the end users, the market has been segmented as hospitals, dermatology clinics and home care.
US accounts for the maximum Xerosis market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the Xerosis market. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India.
The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate Xerosis market growth due to poor economic and political conditions and poor healthcare penetration. The report for Global Xerosis market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.
The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size 2032 | Â USD 14.92 Billion |
| CAGR | Â Â 8.20% (2024-2032) |
| Base Year | Â Â 2023 |
| Forecast Period | Â 2024-2032 |
| Historical Data | Â Â 2020 |
| Forecast Units | Â Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Types, end user, Region |
| Geographies Covered | America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Procter & Gamble, Alba Botanica, Avalon Organics, Johnson & Johnson Consumer Inc., Galderma Laboratories, Clarins, Unilever, Hempz, L’Oréal, Avon, Croda International Plc, Beiersdorf, Estee Lauder, United-Guardian, Inc., Dow Corning Corp. and others. |
Xerosis Market Highlights:
Frequently Asked Questions (FAQ) :
xerosis market is projected to grow at a 8.2% CAGR between 2024-2032.
The US is expected to dominate the xerosis market.
xerosis market is predicted to touch USD 14.92 Billion by 2032.
Major end users of the xerosis market include home care, dermatology clinics, and hospitals.
Key players profiled in the xerosis market include Dow Corning Corp., United-Guardian, Inc., Estee Lauder, Beiersdorf, Croda International Plc, Avon, L’Oréal, Hempz, Unilever, Clarins, Galderma Laboratories, Johnson & Johnson Consumer Inc., Avalon Organics, Alba Botanica, and Procter & Gamble.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
